Advertisement
Screener

PULMONX CORPORATION (LUNG) Increase (Decrease) in Deferred Charges

2.8 / 5 stars · 68/120 Roast Me

PULMONX CORPORATION Increase (Decrease) in Deferred Charges

PULMONX CORPORATION (LUNG) reported Increase (Decrease) in Deferred Charges of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-15.

Discontinued › Cash Flow

us-gaap:IncreaseDecreaseInDeferredCharges · last filed 2021-03-15

  • PULMONX CORPORATION increase (decrease) in deferred charges for fiscal 2020 was $0.00.
  • PULMONX CORPORATION increase (decrease) in deferred charges for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
  • PULMONX CORPORATION increase (decrease) in deferred charges for fiscal 2018 was $62.00K.
Period endIncrease (Decrease) in Deferred Charges 12 month
2020-12-31$0.00
10-K · filed 2021-03-15
2019-12-31$0.00
10-K · filed 2021-03-15
2018-12-31$62.00K
10-K · filed 2021-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
SkinHealth Systems Inc. (SKIN)United States$0.086B-3.17
LENSAR, Inc. (LNSR)United States$0.087B2.02
RenovoRx, Inc. (RNXT)United States$0.076B-3.62
Microbot Medical Inc. (MBOT)$0.089B-7.97
FRACTYL HEALTH, INC. (GUTS)United States$0.075B-1.18
CVRx, Inc. (CVRX)United States$0.067B-2.62
DarioHealth Corp. (DRIO)$0.066B-1.39
TELA Bio, Inc. (TELA)United States$0.057B-0.82
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
Spectral AI, Inc. (MDAI)United States$0.052B